Natarajan Ganesan
Assistant Professor and Assistant Director of Research
Also affiliated: New York Institute of Technology (2025–2026); Georgetown University (2005–2011); University of Madras (1996–1999); Georgetown University Medical Center (2006–2011); New York Institute of Technology (2025–2026); Georgetown Lombardi Comprehensive Cancer Center (2006–2011)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Natarajan Ganesan's research expertise encompasses bioinformatics, genomics, and personalized medicine. His earlier work focused on cancer research and therapeutics. He has experience in developing and managing web-based interfaces for bioscience researchers and has worked with public databases, including at the National Institutes of Health (NIH).
Ganesan has collaborated with researchers across academia, pharmaceutical, and biotechnology sectors. His diverse projects have included work on wireless biosensors and the linguistic fingerprinting of peptide sequences. He has also contributed to business strategy and market analysis reports for healthcare organizations and international companies. He has served as an invited reviewer for grant panels, including for the Department of Defense and Fulbright.
His scholarly contributions are reflected in a h-index of 9, with 40 publications and 321 citations. His recent work includes investigations into the disruption of transforming growth factor-β signaling in hepatocellular cancer, altered expression of epigenetic regulators in cancer cell lines, and the development of biosensors. He has also explored the role of gamma-radiation-induced chromosomal mutational sensitivity in breast cancer risk and the effects of cisplatin on *C. albicans*.
Metrics
- h-index: 9
- Publications: 48
- Citations: 335
Positions
-
Assistant Professor and Assistant Director of Research 2023–presentNew York Institute of Technology Biomedical and Anatomical Science ORCID
-
Assistant Professor and Assistant Director of Research publications 2026Arkansas State University ORCID
Selected Publications
-
Abstract 4193: Heterogeneous graph neural network meta-analysis of lung cancer and tuberculosis transcriptomic datasets reveals convergent host response networks (2026)
-
Abstract 7283: Genomic landscape of IDH-wild-type glioblastoma in a patient treated with TNF-alpha inhibitor: Implications for risk stratification and therapeutic decision-making (2026)
Collaboration Network
Top Collaborators
- Abstract 7283: Genomic landscape of IDH-wild-type glioblastoma in a patient treated with TNF-alpha inhibitor: Implications for risk stratification and therapeutic decision-making
- Abstract 4193: Heterogeneous graph neural network meta-analysis of lung cancer and tuberculosis transcriptomic datasets reveals convergent host response networks
- Abstract 4193: Heterogeneous graph neural network meta-analysis of lung cancer and tuberculosis transcriptomic datasets reveals convergent host response networks
Similar Researchers
Based on overlapping research topics